Found: 22
Select item for more details and to access through your institution.
A survey of the population genetic variation in the human kinome.
- Published in:
- Journal of Human Genetics, 2009, v. 54, n. 8, p. 488, doi. 10.1038/jhg.2009.72
- By:
- Publication type:
- Article
AAA: triple adaptive Bayesian designs for the identification of optimal dose combinations in dual‐agent dose finding trials.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 2, p. 385, doi. 10.1111/rssc.12291
- By:
- Publication type:
- Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4583, doi. 10.1245/s10434-021-11249-7
- By:
- Publication type:
- Article
Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 8, p. 4433, doi. 10.1245/s10434-020-09475-6
- By:
- Publication type:
- Article
Novel Application of Iterative Hyperthermic Intraperitoneal Chemotherapy for Unresectable Peritoneal Metastases from High-Grade Appendiceal Ex-Goblet Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 3, p. 1777, doi. 10.1245/s10434-020-09064-7
- By:
- Publication type:
- Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Keeping Checkpoint Inhibitors in Check.
- Published in:
- 2019
- By:
- Publication type:
- Opinion
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 905, doi. 10.1093/oncolo/oyac174
- By:
- Publication type:
- Article
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing.
- Published in:
- Oncologist, 2014, v. 19, n. 3, p. 235, doi. 10.1634/theoncologist.2013-0352
- By:
- Publication type:
- Article
Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with <i>MET</i> Gene Amplification in FFPE Tumor Tissue.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0100586
- By:
- Publication type:
- Article
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0054014
- By:
- Publication type:
- Article
A subgroup cluster-based Bayesian adaptive design for precision medicine.
- Published in:
- Biometrics, 2017, v. 73, n. 2, p. 367, doi. 10.1111/biom.12613
- By:
- Publication type:
- Article
A UGT1A1 genotype‐guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 10, p. 1629, doi. 10.1002/cncr.31938
- By:
- Publication type:
- Article
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Next-Generation Companion Diagnostics.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of the Association of Perioperative UGT1A1 Genotype–Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 2, p. e1921290, doi. 10.1001/jamanetworkopen.2019.21290
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibition in the Treatment of Gastro-Esophageal Cancer: A Closer Look at the Emerging Evidence.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5929, doi. 10.3390/cancers13235929
- By:
- Publication type:
- Article
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 4, p. 175
- By:
- Publication type:
- Article
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-66
- By:
- Publication type:
- Article